Clinic
Ihc Health Services, INC.
Ihc Health Services, INC. was paid $3.87M by Medicaid between Jan 2018 and Nov 2024, across 114 billing codes. Its largest line is 8888888, Internal/system code - not a standard HCPCS code — 37% of everything it billed.
33Billing provider infoIHC HEALTH SERVICES, INC.
RICHFIELD, UT 84701
RICHFIELD, UT 84701
33aNPI1336256775assigned 08/23/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$3.87M
24GClaims88,356
24DCodes billed114
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Utah
Rank by total paid#4 of 25
Median peer was paid$166K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SMITH, DENIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,908 | $395K | |
| 2019 | 14,940 | $416K | |
| 2020 | 14,840 | $599K | |
| 2021 | 21,582 | $1.14M | |
| 2022 | 19,891 | $1.14M | |
| 2023 | 1,733 | $158K | |
| 2024incomplete | 462 | $28K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 8888888 | Internal/system code - not a standard HCPCS code | 37% | 1,591 | 780 | $1.45M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 11% | 8,245 | 6,835 | $427K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 6.9% | 1,458 | 1,296 | $268K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.7% | 4,848 | 4,465 | $261K |
| 80050 | General health panel | 5.6% | 1,983 | 1,891 | $217K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3.9% | 922 | 885 | $152K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3.7% | 1,297 | 1,172 | $144K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 1,746 | 1,649 | $126K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.7% | 3,447 | 3,114 | $105K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.4% | 2,100 | 1,807 | $93K |
| 71046 | Radiologic examination, chest; 2 views | 1.2% | 1,292 | 1,208 | $48K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1.1% | 2,191 | 1,937 | $43K |
102 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 1,425 | $42K |
| 81001 | <1% | 3,106 | $36K | |
| 81025 | <1% | 660 | $35K | |
| 80053 | Comprehensive metabolic panel | <1% | 7,564 | $30K |
| 99285 | Emergency room visit (most serious) | <1% | 1,857 | $29K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,006 | $25K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,672 | $23K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 461 | $21K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 549 | $19K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,565 | $16K |
| 80306 | <1% | 213 | $14K | |
| 73562 | <1% | 215 | $13K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,550 | $11K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 758 | $11K |
| 73030 | <1% | 135 | $11K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 639 | $10K |
| 87186 | <1% | 691 | $10K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,844 | $9K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 82 | $9K |
| 71045 | Radiologic examination, chest; single view | <1% | 939 | $9K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 618 | $8K |
| 85027 | <1% | 289 | $8K | |
| 73110 | <1% | 74 | $7K | |
| 73630 | <1% | 142 | $7K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 66 | $7K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 603 | $6K |
| 73610 | <1% | 104 | $6K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 72 | $6K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,713 | $5K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,125 | $5K |
| 80061 | Lipid panel | <1% | 1,632 | $5K |
| 87631 | <1% | 51 | $4K | |
| 84439 | <1% | 1,209 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 132 | $4K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 225 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,060 | $4K |
| 84702 | <1% | 289 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 76 | $3K |
| 87660 | <1% | 101 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 190 | $3K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 419 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 633 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 32 | $3K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 700 | $3K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 54 | $3K |
| 87480 | <1% | 101 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 28 | $2K |
| 83735 | <1% | 724 | $2K | |
| 73590 | <1% | 14 | $2K | |
| 76801 | <1% | 28 | $2K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 50 | $2K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,050 | $2K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 423 | $1K |
| 84484 | <1% | 869 | $1K | |
| 82607 | <1% | 838 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 14 | $1K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 161 | $1K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 258 | $1K |
| 83690 | <1% | 1,345 | $972.27 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 12 | $950.96 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 159 | $869.43 |
| 74018 | <1% | 17 | $840.09 | |
| 83880 | <1% | 209 | $837.52 | |
| 72100 | <1% | 13 | $780.61 | |
| 81003 | <1% | 74 | $776.00 | |
| 82570 | <1% | 406 | $719.42 | |
| 84466 | <1% | 72 | $713.11 | |
| 85610 | <1% | 856 | $671.97 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 49 | $605.65 |
| 87070 | <1% | 37 | $540.39 | |
| 87081 | <1% | 51 | $529.54 | |
| 86140 | <1% | 1,341 | $516.10 | |
| 96376 | <1% | 58 | $510.56 | |
| 83605 | <1% | 1,185 | $499.27 | |
| 87088 | <1% | 401 | $436.35 | |
| 85379 | <1% | 375 | $362.36 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 75 | $215.98 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 772 | $149.41 |
| 82728 | <1% | 45 | $126.45 | |
| 80069 | <1% | 12 | $105.82 | |
| 82043 | <1% | 45 | $73.72 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 28 | $56.14 |
| 87807 | <1% | 32 | $45.87 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,389 | $38.62 |
| 85651 | <1% | 669 | $24.87 | |
| 90686 | <1% | 28 | $24.04 | |
| 84703 | <1% | 25 | $10.60 | |
| 86803 | <1% | 57 | $10.27 | |
| 83615 | <1% | 66 | $8.72 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 55 | $4.46 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 14 | $2.38 |
| 83540 | 0% | 87 | $0.00 | |
| 62323 | 0% | 13 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 14 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 12 | $0.00 |
| 84481 | 0% | 13 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 819 | $0.00 |
| 87510 | 0% | 101 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 67 | $0.00 |
| 85730 | 0% | 13 | $0.00 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, DENIS (CFO)
| Provider | Location | Paid |
|---|---|---|
| Ihc Health Services, INC. | Murray, UT | $68.77M |
| Ihc Health Services, INC. | St George, UT | $65.78M |
| Ihc Health Services INC | Ogden, UT | $54.08M |
| Ihc Health Services, INC. | Provo, UT | $44.35M |
| Ihc Health Services INC | Logan, UT | $25.34M |
| Ihc Health Services, INC. | Cedar City, UT | $20.40M |
| Ihc Health Services, INC. | Salt Lake City, UT | $19.91M |
| Ihc Health Services, INC. | American Fork, UT | $17.19M |
| Ihc Health Services INC | Riverton, UT | $15.31M |
| Ihc Health Services INC | Sandy, UT | $11.66M |
| Ihc Health Services, INC. | Layton, UT | $11.61M |
| Ihc Health Services, INC. | Burley, ID | $5.14M |
| Ihc Health Services INC | Murray, UT | $4.64M |
| Ihc Health Services INC | St George, UT | $4.35M |
| Ihc Health Services INC | Heber City, UT | $4.31M |
| Ihc Health Services, INC. | Orem, UT | $4.18M |
| Ihc Health Services INC | Tremonton, UT | $3.55M |
| Ihc Health Services, INC. | Spanish Fork, UT | $3.49M |
| Ihc Health Services INC | Park City, UT | $2.53M |
| Ihc Health Services, INC. | Mt Pleasant, UT | $2.34M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.